S&P 500 (NYSE:SPY) component PSS World Medical (PSSI) reported its results for the most recent quarter. PSS World Medical, Inc. is a national distributor of medical products and equipment, pharmaceutical products, healthcare information technology and billing services to alternate-site healthcare providers.
Results: Net income for the company rose to $21.6 million (38 cents/share) from $16.5 million in the year ago quarter.
Actual vs. Wall St. Expectations: PSSI beat the mean analyst estimate of 37 cents/share. Estimates ranged from 36 cents per share to 38 cents per share.
Quoting Management: Gary A. Corless, President and Chief Executive Officer, commented, “We refined our Company’s purpose — to strengthen the clinical success and financial health of caregivers by solving their biggest problems. During the past year, this purpose has led us to expand our services, products, and businesses to lead in the pursuit of a more efficient and effective future for the U.S. healthcare system. Our team continued to perform very well in the fourth quarter of fiscal year 2011 with solid revenue growth of more than 15% in our Physician Business, consolidated operating margin expansion of 117 basis points, and impressive earnings per diluted share growth of 36%. Strong execution throughout the year resulted in our achieving $1.32 in earnings per diluted share, the high end of our goal for the full year.”
Competitors to Watch: Henry Schein, Inc. (NASDAQ:HSIC), Chindex Intl., Inc. (NASDAQ:CHDX), Patterson Companies, Inc. (NASDAQ:PDCO), Owens & Minor, Inc. (NYSE:OMI), Lincare Holdings Inc. (NASDAQ:LNCR), Cardinal Health, Inc. (NYSE:CAH), McKesson (NYSE:MCK), Integra LifeSciences (NASDAQ:IART), Thermo Fisher (NYSE:TMO), Teleflex (NYSE:TFX), Covidien (NYSE:COV), Omnicare (NYSE:OCR) and AmerisourceBergen Corp. (NYSE:ABC).
Stock Performance: Shares of PSSI are unchanged following yesterday’s close of $28.87.